US$ 22.73
wada prohibited list 2025 s0 unapproved substances bpc 157 Athlete Advisory: What's New on the List? WADA publishes 2026 Prohibited List
Description
Development by Metabolic Pharmaceuticals was terminated in 2007 for that reason

A very high dosage of any of these ingredients could potentially result in anxiety, faster heartbeats, or increased blood pressure

Anything that could POSSIBLY make my neck warm is just intolerable

Excessive doses can leads to potential risks such as inhibition of breast milk production

Supporting General Health & Wellness

We have seen extracts with only 4% glabridin as well as 40% glabridin
